TP53 and prostate carcinoma: The structural variants in 8 cases of prostatic carcinoma included breakpoints in intron 1 (N = 5), intron 2 (N = 1), exon 1 (N = 1) and intron 10 of TP53 (Fig 2) and are predicted to result in loss of gene expression.